JXJian-He Xu

Jian-He Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jian-He Xu has a total of 531 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Blocking, Widening, Regulating, and Tailoring-Based Engineering of an Imine Reductase for Asymmetric Reductive Amination of Sterically Demanding Ketones with Ammonia

    by Hong-Yue Wang, Shao-Jun Li, Zhen-Yu Zhu, Chuang Li, Zhi Zhang, Cheng Cheng, Qi Chen, Jian-He Xu, Gao-Wei Zheng

    Chiral amines are essential building blocks for the synthesis of pharmaceuticals. Although imine reductases (IREDs) have emerged as powerful biocatalysts for chiral amine synthesis, their application in reductive amination using ammonia as an amino donor remains limited, especially for sterically demanding ketone substrates. Herein, we developed a BWRT (Blocking, Widening, Regulating, and Tailoring) strategy for engineering the active-site pocket of an IRED from Saccharopolyspora erythraea (SeIRED). The engineered variant, SeIRED-M4, containing 17 amino acid mutations, exhibited a 23,300-fold increase in specific activity along with a 19 °C increase in melting temperature (Tm) relative to the wild-type enzyme. SeIRED-M4 efficiently catalyzed the asymmetric reductive amination of a broad range of ketones with ammonia, affording the corresponding chiral amines with up to 98% conversion and >99% ee. The synthetic applicability of SeIRED-M4 was further demonstrated through the gram-scale synthesis of sitagliptin ((R)-1b), achieving 93% conversion and >99% ee at a substrate loading of up to 40 g/L. Collectively, this study demonstrates an active-site engineering strategy that improves catalytic performance by regulating substrate accessibility and productive binding orientation, highlighting the importance of controlling substrate-binding conformations in biocatalyst development for pharmaceutical applications.

  • Loop‐Centric Engineering of Terminal Deoxynucleotidyl Transferase for Enhanced Catalysis of 3'‐Modified Nucleotides

    by Kun Shi, An‐Na Li, Jian‐He Xu, Hui‐Lei Yu

    Efficient enzymatic DNA synthesis requires terminal deoxynucleotidyl transferases (TdTs) that can accept reversibly blocked nucleotides, but improving wild‐type enzymes has traditionally depended on labor‐intensive screening. Here, we combine deep learning‐based structure prediction with molecular dynamics simulations to guide loop‐centric engineering of a TdT from Crocodylus porosus . The resulting variant M3 (V253E/L256M/N338R) showed a 26‐fold increase in specific activity toward 3'‐ONH 2 ‐dCTP while maintaining expression and thermostability. Simulations indicated that the mutations reorganized Loop1 dynamics and reproducibly biased the incoming nucleotide toward a more favorable in‐line attack orientation. The key N338R change also improved a second TdT scaffold, supporting N338 as a potentially transferable engineering hotspot. These results provide a practical computational strategy for improving terminal deoxynucleotidyl transferases for incorporation of 3′‐modified nucleotides, reducing reliance on large‐scale screening.

  • A sustainable and tunable methanol-driven sesquiterpene-biomanufacturing platform using engineered Komagataella phaffii

    by Nuo Zhang, Zheng-Yu Huang, Xing-Kai Li, Gao-Wei Zheng, Chun-Xiu Li, Jian-He Xu

  • Open Access

    An Engineered β‐Aminopeptidase With Better Product Selectivity for L‐Carnosine Production

    by Bi‐Han Guan, Wu‐Tong Yin, Chen Zhao, Jiang Pan, Jian‐He Xu

    Efficient enzymaticsynthesis of L‐carnosine (L‐Car) is often limited by competing hydrolysis and side reactions that reduce substrate utilization and product yield. In this study, a β‐aminopeptidase ( Cb AP) from Caulobacter sp. was systematically engineered to enhance catalytic selectivity toward L‐Car using β‐alaninamide and L‐histidine as substrates. Analysis of β‐alaninamide‐derived byproducts revealed two major competing pathways, namely β‐alaninamide hydrolysis and self‐ligation into short oligopeptides. To evaluate the balance between L‐Car synthesis and competing reactions, a composite apparent selectivity index ( R S ) was introduced. Structure‐guided mutagenesis targeting residues within 4–6 Å of the active site identified several improved variants. Iterative combination of beneficial mutations yielded the optimal mutant Cb AP Q138FF96Y ( Cb AP M2 ), exhibiting an approximately 2.3‐fold increase in R S relative to Q138F and an approximately 3.1‐fold increase relative to the wild‐type enzyme, with substantial suppression of undesired side reactions. Molecular dynamics simulations indicated that these improvements arise from reduced substrate binding stability and disrupted hydrogen‐bonding interactions with β‐alaninamide and L‐Car. Under optimized 10 mL‐scale conditions, Cb AP M2 produced 37.3 mM L‐Car within 1 h, corresponding to a 74.6% yield based on β‐alanine methyl ester, with an STY of 8.44 g L − 1 h −1 .

  • Probing the Catalytic Promiscuity and Enhancing the Efficiency of CYP725A4 with a Taxadiene Substrate Mimic

    by Longhao Huang, Mingyuan Lai, Zihan Zhang, Lili Zhu, Ran Hong, Jian-He Xu, Hui-Lei Yu

    The catalytic promiscuity of cytochrome P450 CYP725A4 severely impedes paclitaxel biosynthesis, as it generates taxadien-5α-ol (T-5α-ol) alongside numerous by-products. Despite diverse proposed mechanisms and the reported role of facilitator of taxane oxidation (FoTO1) in promoting T-5α-ol formation, conclusive evidence elucidating the catalytic promiscuity of CYP725A4 remains elusive. Here, we report a substrate mimic strategy using taxadien-2-one (taxadienone), which is selectively epoxidized by CYP725A4 at the C4=C5 double bond, suggesting epoxidation as its major catalytic pathway. This notion was then confirmed by the successful identification of the long-observed yet structurally uncharacterized major taxadiene oxidation product as 4(5)α-epoxy-taxadiene, which can spontaneously rearrange in solution. Furthermore, the minor T-5α-ol produced by CYP725A4 arises from a concurrent hydroxylation pathway rather than from epoxidation, and efficient isomerization of 4(5)α-epoxy-taxadiene to T-5α-ol by FoTO1 is required to achieve improved product selectivity. Employing the promiscuity-free taxadienone as a probe substrate eliminated analytical complications and led to variant M3, which shows markedly enhanced catalytic activity through optimized heme-binding and enhanced FG loop flexibility. Finally, co-expressing the plant-derived FoTO1 with the CYP725A4 variant M3 in engineered Escherichia coli increased T-5α-ol production to 109.1 mg/L in a 5 L bioreactor. Collectively, this strategy provides crucial insights into CYP725A4 catalytic promiscuity and enables more efficient directed evolution, thereby facilitating downstream paclitaxel pathway optimization.


  • Controlled Synthesis of Chiral β-Chloramines and Aziridines via an Organo- and Biocatalytic Cascade.

    by Zhen-Yu Zhu, Zi-Wei Xia, Zi-Yi Huang, Yu-Zhu Zou, Min Shi, Xin-Yuan Shen, Tian Jin, Yun-Fei Gao, Dan Li, Yong-Tao Xie, et al.

    Chiral organochlorides bearing C-Cl stereocenters are highly desirable motifs in synthetic and medicinal chemistry, yet their direct asymmetric synthesis from simple starting materials via biocatalysis alone remains challenging. Here, we report an integrated organo- and biocatalytic cascade that converts readily available aldehydes into enantiomerically enriched β-chloramines. Under optimized near-neutral conditions, the method delivers a broad array of β-chloramines in high yield (up to 88%) with exceptional enantioselectivity (up to >99:1 enantiomeric ratio). Notably, by simply raising the pH to 9.5, the same cascade system diverges to directly generate chiral aziridines, enabling pH-controlled access to two valuable product classes from a unified platform. The utility of this strategy is further demonstrated by preparative-scale syntheses from inexpensive commercial substrates, followed by divergent linchpin transformations to diverse chiral building blocks, including aziridines, azido amines, and acetoxy amines. Mechanistic studies provide insight into the origins of stereoselectivity and the key factors governing stereochemical outcomes.


  • Efficient Synthesis of Ergothioneine in Escherichia coli Through Identification of Bacterial‐Type Egt1 and Self‐Assemble of Pathway Enzymes

    by Xin‐Yi Chen, Shuai Yan, Hang‐Cheng Li, Hai‐Ping Liu, Hui‐Lei Yu, Jian‐He Xu, Zhi‐Jun Zhang

    Ergothioneine (EGT) offers diverse physiological benefits and potential applications. Production of EGT by engineered bacterial strain has emerged as an eco‐friendly and cost‐effective alternative to traditional extraction and chemical synthesis methods. The fungal pathway requires only two steps and is simpler than the bacterial pathway, which typically requires three or five steps depending on the catalytic characteristics of EgtB. However, heterologous overexpression of fungal enzymes in Escherichia coli still represents a great challenge, which would limit the practical application of fungal pathway for EGT biosynthesis. In this study, a bacterial‐type Egt1 with catalytic function similar to that of the fungal Egt1 was identified by genome data mining, enabling the construction of the simplest bacterial EGT biosynthetic pathway. The pathway was introduced into E. coli resulting in an EGT titer of 426 mg/L. Cip‐based self‐assemble of enzymes requires only one scaffold protein and occurs spontaneously, which has been employed to aggregate the rate‐limiting enzymes of biosynthetic pathway to speed up the desired reaction via substrate channeling effects. The pathway enzymes were self‐assembled using the CipB scaffold protein. The optimal engineered strain E48 produced 925 mg/L of EGT in shake flask after 72 h cultivation, with a productivity of 13 mg/(L·h). Finally, the production of EGT was scaled up in a 5 L fermenter, with an EGT titer reaching 1934 mg/L and a productivity of 36.5 mg/(L·h) after 55 h of fermentation. This study provides new approach for the efficient synthesis of EGT and other value‐added bioactive molecules.


  • Engineering P450 Peroxygenase Overoxidation Promiscuity Enables Concise and High-Yielding Biocatalytic Synthesis of d -Amino Acids from Fatty Acids

    by Xing Yu, Peng Deng, Sheng Gu, Bu-Bing Zeng, Hui-Lei Yu, Jian-He Xu, Zhi-Jun Zhang

    Direct asymmetric α-C−H bond amination of carboxylic acids is an attractive route to optically active α-amino acids from inexpensive, renewable starting materials. However, traditional chemical methods suffer from expensive catalysts and environmental concerns, while recently developed multienzyme cascades are limited by complex auxiliary enzyme requirements and narrow substrate scope. Here, we report an engineered P450 peroxygenase (P450CLA-M5) with enhanced overoxidation promiscuity that enables the direct conversion of fatty acids to α-keto acids. Coupling this enzyme with d-amino acid dehydrogenase and formate dehydrogenase establishes a biocatalytic cascade for the C−H amination of fatty acids to d-amino acids. Saturated, unsaturated, and aromatic fatty acids were converted to the corresponding d-amino acids with yields up to 94% and >99% ee. Specifically, the yield of d-2-aminodecanoic acid represents a 15-fold improvement over previous biocatalytic approaches. This work demonstrates how engineering increased enzyme promiscuity can enhance cascade efficiency for the synthesis of valuable chiral d-amino acids from renewable feedstocks.


  • Dual Flow Reactor Approach for the Chemoenzymatic Production of Chenodeoxycholic Acid, a Precursor to Ursodeoxycholic Acid

    by Bing-Yi Yang, Ya-Jing Liu, Jiang Pan, Gao-Wei Zheng, Jian-He Xu, Chun-Xiu Li

    Chenodeoxycholic acid, a precursor to ursodeoxycholic acid, can be synthesized from inexpensive cholic acid through a two-step chemoenzymatic route. Here, a dual flow reactor system was developed to intensify this process. First, a packed-bed reactor with coimmobilized enzymes achieved complete conversion of 50 mM cholic acid to 12-oxochenodeoxycholic acid, achieving a space-time yield of 5831 g·L–1·d–1, significantly surpassing the batch mode (1632 g·L–1·d–1). Subsequently, a PTFE flow reactor facilitated the Wolff–Kishner–Huang reduction, producing chenodeoxycholic acid with a space-time yield of 3629 g·L–1·d–1, outperforming the batch mode (1555 g·L–1·d–1). This work highlights a safe and efficient platform for chemoenzymatic chenodeoxycholic acid synthesis and provides a generalizable strategy for industrial bile acid production.